Tourette Syndrome
📧 Sign up to get email alerts when something new happens for Tourette Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Impulsivity in Tourette Syndrome : Behavioral and Neuroimaging Study [NA]
A completed research study examining impulsivity in Tourette syndrome using behavioral assessments and neuroimaging methods (NCT02960698).
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression [NA]
Clinical trial update on deep brain stimulation targeting for Tourette syndrome, focusing on detecting targets and suppression; the study is…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder [Phase 3]
A Phase 3 trial update evaluating the long-term safety of Ecopipam in children, adolescents, and adults with Tourette's disorder; the study …
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Neurofeedback From the Supplementary Motor Area for Tourette Syndrome [NA]
A clinical trial update shows a Yale University study on neurofeedback from the supplementary motor area for Tourette syndrome in adolescenc…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Trajectories of Change in Tourette Syndrome [NA]
Ongoing clinical trial studying trajectories of change in Tourette syndrome and tic disorders, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study [NA]
A clinical trial update about a double-blind, randomized study using transcranial magnetic stimulation to strengthen CBIT (comprehensive beh…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders [Phase 2]
A Phase 2 trial is evaluating sertraline versus placebo for anxiety in children and adolescents with neurodevelopmental disorders, including…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics [Phase 2]
This update covers an ongoing Phase 2 trial that uses multimodal profiling to evaluate response to Pediatric Comprehensive Behavioral Interv…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Cognitive-psychophysiological Treatment for Tics in Young People With Tourette's Syndrome With or Without Biofeedback [NA]
A clinical trial is evaluating a cognitive-psychophysiological treatment for tics in young people with Tourette syndrome, with or without bi…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Deep Brain Stimulation in Tourette Syndrome [NA]
This document reports the completion of a clinical trial evaluating deep brain stimulation for Tourette syndrome. The study was sponsored by…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics [NA]
A University of Utah-sponsored clinical trial is currently recruiting to examine changes in premonitory urges during habit reversal training…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Multitarget Stereotactic Electrophysiological Recording and Stimulation for Tourette Syndrome [NA]
Clinical trial evaluating multitarget stereotactic electrophysiological recording and stimulation for Tourette syndrome is currently recruit…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Remote Delivery of a Mindfulness-based Intervention for Tics [NA]
Johns Hopkins University is conducting a trial to assess remote delivery of a mindfulness-based intervention for Tourette syndrome and rela…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Longitudinal Impact of Stressors in Adults With Tourette Syndrome
A clinical trial is evaluating the longitudinal impact of stressors in adults with Tourette Syndrome. It is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Multimodal Electrophysiological Study of Cortico-subcortical Biomarkers of Tics in Tourette Syndrome [NA]
A recruiting clinical study at University Hospital, Bordeaux is evaluating multimodal electrophysiological biomarkers of tics in Tourette sy…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder [NA]
An ongoing clinical trial is evaluating forehead temperature-regulating therapy to treat insomnia in adults with Tourette syndrome; recruitm…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics [NA]
Completed study evaluating transcranial magnetic stimulation to augment behavior therapy for tic disorders; results were posted on 2025-03-0…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Development and Application of a Diagnosis and Treatment System for Children's Brain Diseases Based on Knowledge Graphs and Large Models
This clinical trial aims to develop and apply a diagnosis and treatment system for pediatric brain diseases using knowledge graphs and large…
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Haloperidol lactate from Fresenius Kabi USA, LLC.
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Innogenix, Inc.)
FDA approved a supplemental application for HALOPERIDOL submitted by Innogenix, Inc., marking an approved update to the product through a su…
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (AiPing Pharmaceutical, Inc)
FDA approved AiPing Pharmaceutical's supplemental application for haloperidol, a generic antipsychotic.
-
FDA label_change · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental labeling application for HALOPERIDOL from Zydus Lifesciences Limited, updating the existing product labeling…
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for HALOPERIDOL submitted by Lannett Company, Inc., authorizing changes to the product's approva…
-
CLINICAL_TRIALS research · 2025-01-21Clinical Trial Update: Effect of RNS in Treatment-refractory Tourette's Syndrome [NA]
This clinical trial update notes that a study evaluating the effect of a responsive neurostimulation (RNS) device for treatment-refractory T…
-
FDA approval · 2025-01-16FDA Approved: HALOPERIDOL LACTATE — Supplemental Application (Mylan Institutional LLC)
FDA granted a supplemental approval for HALOPERIDOL LACTATE to Mylan Institutional LLC, issuing a supplemental application for this generic …